udo s gaipl
University Hospital Erlangen
Erlangen, Germany
Associate Editor
Cancer Immunity and Immunotherapy
University Hospital Erlangen
Erlangen, Germany
Associate Editor
Cancer Immunity and Immunotherapy
Haematology-Oncology and Stem Cell Transplantation Unit, Department of Haematology and Innovative Diagnostics, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale
Napoli, Italy
Associate Editor
Cancer Immunity and Immunotherapy
Ospedale San Giovanni Bosco
Turin, Italy
Associate Editor
Thoracic Oncology
University of Pisa
Pisa, Italy
Associate Editor
Hematologic Malignancies
Adicet Bio, Inc
Menlo Park, United States
Associate Editor
Cancer Immunity and Immunotherapy
Surgical Oncology - University Vanvitelli of Naples -
Naples, Italy
Associate Editor
Surgical Oncology
Rudjer Boskovic Institute
Zagreb, Croatia
Associate Editor
Pharmacology of Anti-Cancer Drugs
Hospital de Sabadell
Barcelona, Spain
Associate Editor
Genitourinary Oncology
National Institute of Cardiology Ignacio Chavez
Mexico, Mexico
Associate Editor
Cancer Metabolism
Université Catholique de Louvain
Louvain-la-Neuve, Belgium
Associate Editor
Pharmacology of Anti-Cancer Drugs
King's College London
London, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
National Cancer Institute (NIH)
Rockville, United States
Associate Editor
Cancer Immunity and Immunotherapy
Cleveland Clinic
Cleveland, United States
Associate Editor
Gynecological Oncology
School of Medicine, University of Maryland
Baltimore, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
King's College Hospital NHS Foundation Trust
London, United Kingdom
Associate Editor
Hematologic Malignancies
Affiliated Hospital of Guizhou Medical University
Guiyang, China
Associate Editor
Cancer Imaging and Image-directed Interventions